Correlation Between Hookipa Pharma and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Elevation Oncology, you can compare the effects of market volatilities on Hookipa Pharma and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Elevation Oncology.
Diversification Opportunities for Hookipa Pharma and Elevation Oncology
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Hookipa and Elevation is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Elevation Oncology go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Elevation Oncology
Given the investment horizon of 90 days Hookipa Pharma is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Hookipa Pharma is 1.2 times less risky than Elevation Oncology. The stock trades about -0.49 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 60.00 in Elevation Oncology on August 28, 2024 and sell it today you would earn a total of 1.00 from holding Elevation Oncology or generate 1.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hookipa Pharma vs. Elevation Oncology
Performance |
| Timeline |
| Hookipa Pharma |
| Elevation Oncology |
Hookipa Pharma and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hookipa Pharma and Elevation Oncology
The main advantage of trading using opposite Hookipa Pharma and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |